| Abstract | The action of 1 alpha-hydroxycholecalciferol (oxydevit) was estimated in 204 patients with renal osteodystrophy, osteoporosis of varying etiology, osteomalacia because of malabsorption, congenital rickets-like diseases. The drug was shown to be highly effective in the treatment of secondary hyperparathyroidism in uremia, steroidal and senile osteoporosis. The treatment involved replacement therapy. |
| Authors | D A Babarykin, N A Reĭsner, A N Riabukha, R L Rozental' |
| Journal | Terapevticheskiĭ arkhiv
(Ter Arkh)
Vol. 63
Issue 11
Pg. 113-6
( 1991)
ISSN: 0040-3660 USSR |
| Vernacular Title | Opyt lecheniia metabolicheskikh osteopatiĭ 1 al'fa-gidroksivitaminom D3 (oksidevitom). |
| PMID | 1810042
(Publication Type: English Abstract, Journal Article)
|
| Chemical References |
- Hydroxycholecalciferols
- 1-hydroxycholecalciferol
|
| Topics |
- Bone Diseases, Metabolic
(drug therapy, metabolism)
- Drug Evaluation
- Female
- Humans
- Hydroxycholecalciferols
(therapeutic use)
- Osteomalacia
(drug therapy, metabolism)
- Osteoporosis
(drug therapy, metabolism)
- Osteoporosis, Postmenopausal
(drug therapy, metabolism)
- Rickets
(congenital, drug therapy, metabolism)
|
